{"id":"W4396871371","doi":"10.1111/jdv.20102","title":"EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; Genentech; LEO Pharma; Medac; European Academy of Dermatology and Venereology; Bausch Health; Deutsche Forschungsgemeinschaft; Argenx; Celltrion; InflaRx; Pfizer; Incyte; Sun Pharma; Deutsche Gesetzliche Unfallversicherung; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Teva Pharmaceutical Industries; Sanofi; Celldex Therapeutics; Amgen; Kiniksa Pharmaceuticals; Celgene; Galderma; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Disease; Population; Etiology; Quality of life (healthcare); Complaint; Prurigo; Psychogenic disease; Intensive care medicine; Dermatology; Psychiatry; Pathology; Nursing","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02871185,0.001640016,0.00261455,0.004028437,0.002912043,0.009082282,0.005982476,0.01787588,0.02295258],"category_scores_gemma":[0.05756962,0.001086452,0.003470051,0.00278993,0.002595397,0.00583037,0.006085477,0.0166656,0.02006217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006188021,"about_ca_system_score_gemma":0.03657796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01815147,"about_ca_topic_score_gemma":0.01457545,"domain_scores_codex":[0.97622,0.005606676,0.003663203,0.001875107,0.009420879,0.003214124],"domain_scores_gemma":[0.9034982,0.02100493,0.007433737,0.003090724,0.05177163,0.01320076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005846613,0.00006290928,0.0005167376,0.001362777,0.00002811208,0.000110898,0.00009448647,0.00007051352,0.0001627919,0.001898867,0.93563,0.06000343],"study_design_scores_gemma":[0.00004610762,0.00004691157,0.001108292,0.004501691,0.00003734197,0.0001771061,0.0001394475,0.00004031166,0.0001045361,0.001424405,0.9923533,0.00002056728],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.0007960303,0.09584083,0.002501047,0.6586863,0.1786001,0.001063425,0.005617332,0.0003629407,0.0565321],"genre_scores_gemma":[0.01667299,0.236568,0.01612926,0.394773,0.1540599,0.00356074,0.02632795,0.001022889,0.1508853],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.02871185,"threshold_uncertainty_score":0.1518446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01970382962617013,"score_gpt":0.2788599527823236,"score_spread":0.2591561231561534,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}